Device Trial Radar · NCT03956563
Effect of Hybrid Laser 10600+1540 nm on GSM
Last checked: Nov 20, 2026Latest source record: May 20, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
30
Planned (sponsor's estimate)
Start
May 15, 2019
Primary completion
May 15, 2020
Study completion Aug 15, 2020
Sponsor
- Lead sponsor
- Quanta System, S.p.A.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 20, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 45 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to clinically confirm, by comparison with a control group, the performance of the 10600 +1540 nm laser in the improvement of atrophic vaginal epithelium at 3 months after the last laser treatment. The secondary objectives are: 1. Confirm the performance of 10600 +1540 nm laser in the improvement of atrophic vaginal epithelium at 9 months post-laser treatment, and compare it with the results at 3 months. 2. Evaluate the improvement of the GSM urinary symptoms and urinary incontinence (UI) and their impact on the Quality of Life, at each timepoint after the first laser treatment. 3. To assess the Patient's Global Impression of Improvement (PGI) with the laser treatment * For the GSM symptoms * For the urinary symptoms and UI 4. To assess the patient's satisfaction with the laser treatment. * For the GSM symptoms * For the urinary symptoms and UI.
Conditions
- Vaginal Atrophy
- Genitourinary Disease
Interventions
Youlaser MT Group 2Device
Youlaser MT is a laser device including two laser sources emitting at 10600 nm (CO2) and 1540 nm (Ga-As) intended to be used for gynaecological applications. Each patient in the control arm will receive 3 simulated laser treatments every 30 days. A placebo consists in a sham device laser that simulates the acoustic signal even if it does not deliver any laser radiation to the subject.
Youlaser MT Group 1Device
Youlaser MT is a laser device including two laser sources emitting at 10600 nm (CO2) and 1540 nm (Ga-As) intended to be used for gynaecological applications. Each patient in the active arm will receive 3 laser treatments with the laser: one treatment administration every 30 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Atrophic vaginal epithelium changeTime frame: 3 months and 9 months post laser treatments
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Obstetrician & Gynecologist Hospital Universitario Sant Joan de Reus
Reus, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.